CGBIO(CEO Hyun-seung Yu), a specialized biotech company in regenerative medicine, announced on the 27th that it has taken a significant first step in providing in-depth professional education through local medical staff by conducting a ‘LUMFIX·NOVOSIS User Workshop’ at the 2024 Spine Surgery Summit held in Yogyakarta, Indonesia. The Indonesian Spine Society (PCI-IOSS) organized the summit in collaboration with the International Society for the Advancement of Spine Surgery (ISASS).
The LUMFIX·NOVOSIS User Workshop was a large-scale global workshop attended by over 200 Indonesian spine specialists. It was an academic session that delved deeply into the advanced applications of LUMFIX, which is used for spinal deformity correction and lesion treatment. This workshop served as an important platform for disseminating the technical know-how of LUMFIX and NOVOSIS both in Indonesia and throughout the Asia-Pacific region, setting a new standard in spinal treatment.
LUMFIX is a device designed to restore the original angle of the spine and prevent further deformation in patients suffering from spinal conditions such as scoliosis where the spine has curved beyond the normal range. NOVOSIS is a bone graft substitute incorporating recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) on a ceramic hydroxyapatite carrier, promoting rapid and effective bone regeneration. Since its official launch in Indonesia in 2021, it has been rapidly expanding its market share in the local market.
Previously, workshops in Indonesia featured presentations by Korean Key Opinion Leaders (KOLs) with extensive experience using the products. However, through the continuous educational programs provided by CGBIO in Indonesia over several years, local physicians have also developed a profound understanding of NOVOSIS. As a result, this workshop featured education and presentations led by renowned Indonesian spine specialists, marking a significant milestone in establishing a ‘self-sustaining medical education ecosystem’ where local doctors educate their peers.
The application methods of LUMFIX were intensively covered through scoliosis cases led by Dr. Pheddy from Eka Hospital and Dr. Andra Hendriarto from Cipto Mangunkusumo Hospital. This event provided particpants with an opportunity to gain the necessary skills and experience in applying LUMFIX to actual patients in various spinal fusion procedures.
Additionally, Dr. Yudha Mathan Sakti from Sardjito General Hospital and Professor Chang-nam Kang from Hanyang University Hospital’s Department of Orthopedic Surgery shared case studies on posterolateral fusion (PLF) and adult spinal deformity correction surgeries using NOVOSIS, the bone graft substitute containing rhBMP-2. This played a crucial role in disseminating the correct application methods of NOVOSIS in various spinal surgeries and attracting new specialists to the field.
CGBIO CEO Hyun-seung Yu stated, “Through this LUMFIX and NOVOSIS user workshop, spine specialists from Indonesia and the Asia-Pacific region shared in-depth knowledge on the practical clinical application of LUMFIX and NOVOSIS and acquired tangible surgical skills. We expect this workshop to serve as a significant turning point, enabling LUMFIX and NOVOSIS to play an expanded role in global medical settings in the future.”
Meanwhile, CGBIO plans to further improve user convenience for medical professionals who have experienced difficulties with the current low-dose formulation by launching NOVOSIS 1mg (high-dose) within the year. This strategic move aims to promote the utilization of NOVOSIS in the global market and accelerate its dissemination by identifying new speakers from various countries, including Indonesia. CGBIO, in particular, plans to solidify its position in the international medical device market by hosting global webinars centered around Indonesian medical professionals, introducing NOVOSIS’s innovative solutions to medical professionals worldwide.
▲ Professor Chang-nam Kang from Hanyang University Hospital’s Department of Orthopedic Surgery giving a presentation.
▲ Participants pose for a commemorative photo at CGBIO’s LUMFIX·NOVOSIS workshop.
